From: Uptake of hepatitis B-HIV co-infection screening and management in a resource limited setting
Characteristics | Hepatitis B positive N = 359 | Hepatitis B negative N = 7683 | P value |
---|---|---|---|
Male gender N (%) | 189 (52.6%) | 2795 (36.4%) | <0.0001 |
Median Age (IQR) in years | 38 (32, 45) | 39 (32, 46) | 0.119 |
WHO stage N (%) 3&4 | 220 (61.3%) | 4388 (57.1%) | 0.156 |
Median CD4 count at hepatitis B test (IQR) cells/μL | 423 (269, 600) | 483 (325, 657) | <0.0001 |
Ever used ART | 337 (93.9%) | 7079(92.1%) | 0.231 |
Current ART regimen N (%) | |||
First line | 316 (88.0%) | 6569 (85.5%) | 0.101 |
Second line ART | 20 (5.6%) | 507 (6.6%) | |
Third line ART | 1 (0.3%) | 1 (0.01%) | |
Median time (days, IQR) from ART start to hepatitis B test | 74 (27, 399) | 105 (28, 596) | < 0.0001 |
Active | 289 (83.2%) | 6801 (88.5%) | <0.0001 |
Dead | 23 (6.5%) | 179 (2.3%) | |
Lost | 5 (1.4%) | 118 (1.5%) | |
Transferred out | 33 (9.6%) | 585 (7.7%) |